Abbott Laboratories reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was USD 11,257 million compared to USD 10,223 million a year ago. Net income was USD 2,018 million compared to USD 1,189 million a year ago. Diluted earnings per share from continuing operations was USD 1.14 compared to USD 0.66 a year ago.
For the six months, sales was USD 23,152 million compared to USD 20,679 million a year ago. Net income was USD 4,465 million compared to USD 2,982 million a year ago. Diluted earnings per share from continuing operations was USD 2.51 compared to USD 1.66 a year ago.